Daphne Haim Langford

Medingo Ltd. engages in developing a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or injections. Medingo's product is Solo MicroPump. The company was founded on November 2, 2005 and is headquartered in Tel Aviv, Israel.

Xenia Venture Capital Ltd. engages in initiation and building of technological companies in the areas of information technology and medical devices. It provides start-ups with professional and supportive environment, including assistance in all business development and company development aspects, follow-on fund raising, strategic counseling,peripheral services pertaining to logistics, finance, and office services. The company was founded in 2004 and is headquartered in Tel Aviv, Israel.

PerAssist Ltd. developed devices to improve blood flow. The firm developed Peri-Boost, a device that offers a viable treatment option for patients facing lower limb amputation due to complications of advanced peripheral artery disease (PAD) patients who are not candidates for angioplasty, atherectomy, or bypass. It has the potential to dramatically reduce the rising number of PVD patients who undergo lower limb amputation due to the inadequate treatment options available. The company was founded by Gaby Weizman and Aaron Hoffman and is headquartered in D.N. Misgav, Israel.

Xenolith Medical Ltd. develops and manufactures medical devices. Its product XenX involves a very thin mesh structure that is constructed as an integral part of a guide wire. The firm is also developing additional tools in the endourological niche. The company was founded by Shaul Shohat and Ido Kilemnik in 2010 and is headquartered in Or Akiva, Israel.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel.